v3.25.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive income
Balance (in shares) at Mar. 31, 2024   61,415,105      
Balance at Mar. 31, 2024 $ 374,508 $ 61 $ 1,070,874 $ (701,282) $ 4,855
Increase (decrease) in Stockholders' Equity          
Issuance of prefunded warrants to purchase common stock, net of issuance costs 48,500   48,500    
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs (in shares)   5,668,937      
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs 48,204 $ 6 48,198    
Foreign currency translation adjustment (432)       (432)
Unrealized loss on short-term investments (99)       (99)
Exercise of pre-funded warrants (in shares)   739,225      
Exercise of pre-funded warrants 1 $ 1      
Exercise of stock options (in shares)   22,860      
Exercise of stock options 66   66    
Vesting of RSUs (in shares)   463,841      
Stock-based compensation expense 9,475   9,475    
Net loss (53,772)     (53,772)  
Balance (in shares) at Jun. 30, 2024   68,309,968      
Balance at Jun. 30, 2024 426,451 $ 68 1,177,113 (755,054) 4,324
Balance (in shares) at Mar. 31, 2024   61,415,105      
Balance at Mar. 31, 2024 374,508 $ 61 1,070,874 (701,282) 4,855
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment 773        
Unrealized loss on short-term investments 531        
Net loss (173,167)        
Balance (in shares) at Dec. 31, 2024   77,009,058      
Balance at Dec. 31, 2024 482,374 $ 77 1,350,587 (874,449) 6,159
Balance (in shares) at Jun. 30, 2024   68,309,968      
Balance at Jun. 30, 2024 426,451 $ 68 1,177,113 (755,054) 4,324
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment (1,905)       (1,905)
Unrealized loss on short-term investments 1,215       1,215
Exercise of stock options (in shares)   34,284      
Exercise of stock options 103   103    
Vesting of RSUs (in shares)   50,336      
Stock-based compensation expense 8,650   8,650    
Net loss (53,055)     (53,055)  
Balance (in shares) at Sep. 30, 2024   68,394,588      
Balance at Sep. 30, 2024 381,459 $ 68 1,185,866 (808,109) 3,634
Increase (decrease) in Stockholders' Equity          
Issuance of prefunded warrants to purchase common stock, net of issuance costs 48,500   48,500    
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs (in shares)   8,538,377      
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs 107,525 $ 9 107,516    
Foreign currency translation adjustment 3,110       3,110
Unrealized loss on short-term investments (585)       (585)
Exercise of pre-funded warrants (in shares)   22,856      
Exercise of pre-funded warrants 66 $ 0 66    
Vesting of RSUs (in shares)   53,237      
Stock-based compensation expense 8,639   8,639    
Net loss (66,340)     (66,340)  
Balance (in shares) at Dec. 31, 2024   77,009,058      
Balance at Dec. 31, 2024 482,374 $ 77 1,350,587 (874,449) 6,159
Balance (in shares) at Mar. 31, 2025   77,085,024      
Balance at Mar. 31, 2025 415,843 $ 77 1,358,897 (948,579) 5,448
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment (938)       (938)
Unrealized loss on short-term investments (269)       (269)
Exercise of stock options (in shares)   966      
Exercise of stock options 8   8    
Vesting of RSUs (in shares)   721,184      
Vesting of RSUs 2 $ 1 1    
Stock-based compensation expense 8,762   8,762    
Net loss (86,693)     (86,693)  
Balance (in shares) at Jun. 30, 2025   77,807,174      
Balance at Jun. 30, 2025 336,715 $ 78 1,367,668 (1,035,272) 4,241
Balance (in shares) at Mar. 31, 2025   77,085,024      
Balance at Mar. 31, 2025 415,843 $ 77 1,358,897 (948,579) 5,448
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment 295        
Unrealized loss on short-term investments $ (179)        
Exercise of stock options (in shares) 70,966        
Net loss $ (240,723)        
Balance (in shares) at Dec. 31, 2025   79,631,167      
Balance at Dec. 31, 2025 210,539 $ 79 1,394,198 (1,189,302) 5,564
Balance (in shares) at Jun. 30, 2025   77,807,174      
Balance at Jun. 30, 2025 336,715 $ 78 1,367,668 (1,035,272) 4,241
Increase (decrease) in Stockholders' Equity          
Foreign currency translation adjustment 751       751
Unrealized loss on short-term investments 131       131
Exercise of pre-funded warrants (in shares)   497,344      
Exercise of pre-funded warrants 501   501    
Vesting of RSUs (in shares)   98,737      
Stock-based compensation expense 8,338   8,338    
Net loss (83,100)     (83,100)  
Balance (in shares) at Sep. 30, 2025   78,403,255      
Balance at Sep. 30, 2025 263,336 $ 78 1,376,507 (1,118,372) 5,123
Increase (decrease) in Stockholders' Equity          
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs (in shares)   1,079,523      
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs 10,364 $ 1 10,363    
Foreign currency translation adjustment 482       482
Unrealized loss on short-term investments (41)       (41)
Exercise of stock options (in shares)   70,000      
Exercise of stock options 281   281    
Vesting of RSUs (in shares)   78,389      
Stock-based compensation expense 7,047   7,047    
Net loss (70,930)     (70,930)  
Balance (in shares) at Dec. 31, 2025   79,631,167      
Balance at Dec. 31, 2025 $ 210,539 $ 79 $ 1,394,198 $ (1,189,302) $ 5,564